Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: chest pain major surgical or invasive procedure: - cabgx2 (lima->lad, svg->diag). mediastinal lymph node biopsy. - cardiac catheterization history of present illness: the patient is a 46-year-old man who presented with angina. he has had a history of several lad stents placed with recurrent thrombosis. this was angioplastied under dr. with good flow to the distal vessel. in addition, the patient has a left upper lobe lung lesion most likely carcinoma. he now presents for surgical revascularization. past medical history: cad -s/p lad stent -s/p anterolateral mi () stent occlusion (s/p lad stent) hypercholesterolemia smoker prior knee surgeries right arthroscopic rotator cuff surgery () medication non-compliance social history: patient is single and has a significant other (). he works in property maintenance. family history: mother died of mi at age 54 (had first mi at earlier age). father w/ cad; died accident. uncle had cabg in 30s when he passed away. oldest brother had angina. physical exam: vitals: bp 107/60, hr 72, rr 20, sat 100% on room air general: well developed male in no acute distress heent: oropharynx benign, good dental health neck: supple, no jvd, transmitted murmur to carotid noted heart: regular rate, normal s1s2 ii/vi diastolic murmur lungs: clear bilaterally abdomen: soft, nontender, normoactive bowel sounds ext: warm, 1+ le edema, no varicosities pulses: 2+ distally neuro: nonfocal pertinent results: 04:45am pt-12.5 ptt-33.4 inr(pt)-1.0 04:45am plt count-223 04:45am glucose-103 urea n-12 creat-0.8 sodium-139 potassium-4.0 chloride-106 total co2-25 anion gap-12 04:45am ck-mb-126* mb indx-14.2* ctropnt-1.35* 09:45am plt smr-normal plt count-200 09:45am wbc-8.0 rbc-unable to hgb-12.1* hct-34.5* mcv-unable to mch-unable to mchc-unable to rdw-unable to 09:45am alt(sgpt)-32 ast(sgot)-128* alk phos-57 tot bili-0.5 09:45am glucose-116* urea n-10 creat-0.8 sodium-136 potassium-4.1 chloride-107 total co2-22 anion gap-11 12:10pm urine blood-neg nitrite-neg protein-neg glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-5.0 leuk-neg 06:45am blood hct-23.4* 04:45am blood plt ct-120* 04:45am blood glucose-101 urean-18 creat-1.0 na-134 k-4.1 cl-100 hco3-27 angap-11 cardiac catheterization 1. selective coronary angiography in this left dominant circulation demonstrated one vessel coronary artery disease. the lmca had mild luminal irregularities. the proximal lad had a 30% stenosis. the proximal lad stents were totally occluded with some retrograde filling of the distal and mid lad by left to left collaterals. the lcx was a large dominant vessel and had mild luminal irregularities. the om1 was a moderate size vessel with moderate diffuse disease. the om2 was also a moderate size vessel without significant obstructive disease. the l-pda was without any significant flow limiting disease. the rca was not engage because it was known to be a diminuitive vessel. 2. resting hemodynamics from right and left heart catheterization demonstrated moderate elevation of right and left heart filling pressures (rvedp 20mmhg, lvedp 23mmhg). there was moderate pulmonary arterial hypertension. there was no mitral stenosis appreciated. there was no transaortic pressure gradient upon catheter pullback from the left ventricle to the ascending aorta. the calculated cardiac output by the fick method was 5.3 l/min with a cardiac index of 2.7. 3. intravascular ultrasound interrogation of the proximal lad verified that the occlusion was secondary to thrombus formation and that the previously deployed stents were well opposed. 4. successful catheter thrombectomy and balloon angioplasty using a 3.25 mm balloon in the proximal lad late stent thrombosis. final angiography demonstrated no residual stenosis, no angiographically apparent dissection, and normal flow (see ptca comments). echo the left atrium is normal in size. no spontaneous echo contrast is seen in the body of the left atrium or left atrial appendage. no mass/thrombus is seen in the left atrium or left atrial appendage. no atrial septal defect is seen by 2d or color doppler. no left ventricular aneurysm is seen. there is moderate regional left ventricular systolic dysfunction. overall left ventricular systolic function is moderately depressed. resting regional wall motion abnormalities include mid anterior, anterior septum and septum ( moderately hypokinetic). the inferior wall is mildly hypokinetic.the remaining left ventricular segments contract normally. right ventricular chamber size and free wall motion are normal. there is simple atheroma in the descending thoracic aorta. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation. there is no aortic valve stenosis. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. mild (1+) mitral regurgitation is seen. there is no pericardial effusion. post bypass the lv function was unchanged and rv function is preserved. aorta was in tact post decannulation. cxr no acute cardiopulmonary process. ekg sinus rhythm with ventricular premature depolarizations. low qrs voltage in the limb leads. extensive anteroseptal and lateral myocardial infarction. compared to the previous tracing of multiple abnormalities as previously noted persist without major change. brief hospital course: mr. was admitted to the on for further work-up of his chest pain. he underwent a cardiac catheterization which was significant for severe single vessel coronary artery disease. given the severity of his disease, the cardiac surgical service was consulted for surgical management. mr. was worked-up in the usual preoperative manner. heparin was continued for anticoagualtion. given his new history of a right upper lobe nodule, the thoracic surgery service was consulted for assistance in his care. a mediastinal lymph node biopsy was recommended during his bypass surgery. on , mr. was taken to the operating room where he underwent coronary artery bypass grafting to two vessels. afterward he was transferred to the cardiac surgery recovery unit in stable condition and awakened neurologically intake. he was weaned from ventilator support, extubated, and pressors were weaned. on pod 2 he was then transferred to the stepdown unit for further recovery. his chest tubes were removed without complication. he was gently diuresed to his preoperative weight, beta blockade and aspirin therapy were resumed, and physical therapy service was consulted to assist with his postoperative strength and mobility. electrolytes were repleted as needed. on pod 3 he his epicardial pacing wires were removed without complication, he continued to improve his ability to ambulate including climbing stairs without respiratory distress or chest pain. a chest xray demonstrated a left lower lobe consolidation for which he was placed on empiric levaquin. on pod 4 mr. was at his preop weight with good exercise tolerance, no sob, or chest pain. his blood pressure was stable. his sternotomy and leg incision were clean, dry, and intact without evidence of infection. he was discharged home on pod 4 with services in good condition, levaquind 500mg po qd for five days, cardiac diet, sternal precautions, and instructed to follow up with his pcp and cardiologist in weeks. he will follow up with dr. in four weeks. medications on admission: asa 325' zocor 20' toprol 50' lisinopril 5' plavix 75' discharge medications: 1. levaquin 500 mg tablet sig: one (1) tablet po once a day for 5 days. disp:*5 tablet(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 5. simvastatin 10 mg tablet sig: two (2) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). disp:*qs mdi* refills:*2* 7. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 8. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 9. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: vna discharge diagnosis: coronary artery disease anterior stemi s/p ptca and stenting hypercholesterolemia htn lung mass discharge condition: good discharge instructions: 1) monitor wounds for signs of infection. these include redness, drainage and increased pain. 2) report any weight gain of greater then 2 pounds in 24 hours or 5 pounds in 1 week. 3) report any fever greater then 100.5. 4) no lifting more then 10 pounds for 10 weeks. 5) no driving for 1 month. 6) followup instructions: follow-up with dr. in 1 month. follow-up with your cardiologist in weeks. follow-up with your primary care physician 2 weeks. call all providers for appointments. procedure: insertion of intercostal catheter for drainage single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters angiocardiography of left heart structures intraoperative cardiac pacemaker injection or infusion of platelet inhibitor diagnostic ultrasound of heart (aorto)coronary bypass of one coronary artery biopsy of lymphatic structure transfusion of packed cells excision of lingual thyroid percutaneous transluminal coronary angioplasty [ptca] procedure on single vessel intravascular imaging of coronary vessels diagnoses: subendocardial infarction, initial episode of care anemia, unspecified pure hypercholesterolemia tobacco use disorder congestive heart failure, unspecified systolic heart failure, unspecified pulmonary collapse other complications due to other cardiac device, implant, and graft family history of ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health swelling, mass, or lump in chest 

Answer: The patient is high likely exposed to